Original Research
Published on 27 Jan 2023
Stimulation of the farnesoid X receptor promotes M2 macrophage polarization
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1065790
- 6,676 views
- 27 citations
14 articles related to "Fxr Agonist"
Articles
Original Research
Published on 23 Nov 2021
Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2021.711448
- 8,125 views
- 30 citations
Original Research
Published on 06 Apr 2023
The roles of serine hydrolases and serum albumin in alisol B 23-acetate hydrolysis in humans
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1160665
- 3,706 views
- 1 citation
Original Research
Published on 28 May 2019
Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00548
- 7,232 views
- 30 citations
Original Research
Published on 15 Jun 2023
Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1197856
- 3,835 views
- 3 citations
Original Research
Published on 22 Jun 2022
GW4064 Alters Gut Microbiota Composition and Counteracts Autism-Associated Behaviors in BTBR T+tf/J Mice
in Microbiome in Health and Disease
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2022.911259
- 7,187 views
- 12 citations
Original Research
Published on 04 Jan 2022
Farnesoid X Receptor Activation in Brain Alters Brown Adipose Tissue Function via the Sympathetic System
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2021.808603
- 7,159 views
- 21 citations
Original Research
Published on 13 Aug 2021
(E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating Glucagon-like Peptide-1 Secretion From Enteroendocrine Cells
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2021.713149
- 10,267 views
- 13 citations
Original Research
Published on 22 Apr 2021
Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages
in Autoimmune and Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2021.632864
- 6,599 views
- 18 citations
Original Research
Published on 30 Mar 2017
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00162
- 9,145 views
- 26 citations
Original Research
Published on 13 Jun 2022
Intrahepatic Cholestasis of Pregnancy Increases Inflammatory Susceptibility in Neonatal Offspring by Modulating Gut Microbiota
in Nutritional Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.889646
- 11,876 views
- 16 citations
Original Research
Published on 09 May 2017
Activation of Sirt1/FXR Signaling Pathway Attenuates Triptolide-Induced Hepatotoxicity in Rats
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00260
- 11,074 views
- 56 citations
Original Research
Published on 01 May 2018
Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00410
- 11,735 views
- 25 citations
Original Research
Published on 10 Feb 2026
Sevelamer inhibits the formation of cholesterol gallstones by modulating bile acid metabolism
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1737631
- 416 views